Search
Scientists have found a protein that empowers prostate tumors to resist hormone therapy.
On Thursday, June 11, at 11:30 AM, 45 high school seniors will participate in the MSK Kids 14th Annual Convocation ceremony. Each year, MSK celebrates our youngest patients (who have all battled cancer or a blood disorder) who are receiving their high school diploma or equivalency.
Very low-dose radiotherapy (VLDRT) is effective for treating grade 3A follicular lymphoma and provides patients with a shorter treatment course and fewer side effects.
Dr. Deb Schrag, Chair of the Department of Medicine, and Dr. Lorenz Studer, Director of the Center for Stem Cell Biology at Memorial Sloan Kettering Cancer Center (MSK), have been elected to the National Academy of Medicine (NAM), one of the highest honors bestowed upon scientists worldwide.
Learn about some of the most important advances in cancer treatment and clinical trials at MSK in 2024.
Memorial Sloan Kettering’s annual seminar exposes high school students and their teachers to cutting-edge scientific research.
philanthropist and art collector Iris Cantor has made a major commitment to Memorial Sloan Kettering Cancer Center to create an endowed chair for a senior researcher in the field of digestive cancers.
Take a look back at some of the biggest cancer science stories from this past year.
A team of experts at Memorial Sloan Kettering shared their insights on prostate cancer and men’s health in an Information Session for patients, caregivers and those at increased risk for the disease.
The largest study of its kind to look at data from children with cancer finds inherited cancer genes are more common than expected.